Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients [version 1; peer review: 1 approved, 1 approved with reservations]

Background: With the availability of direct acting antiviral treatment for hepatitis C (HCV), HIV and HCV co-infected patients show comparable treatment responses to HCV-monoinfected patients. An 8-week course of sofosbuvir/ledipasvir (SOF/LDV) is highly effective for the treatment of HCV genotype 1...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	F1000 research 2017, Vol.6, p.620
Hauptverfasser:	Ogbuagu, Onyema, Hao, Ritche, Virata, Michael, Villanueva, Merceditas S, Malinis, Maricar
Format:	Artikel
Sprache:	eng
Schlagworte:	HIV Infection & AIDS: Clinical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!